- Fresenius Kabi launches FDA-approved, cost-effective generic Cetrorelix Acetate for Injection, equivalent to Cetrotide®, for women’s health.
August 27 2024 12:02:04 UTC– Fresenius Kabi introduces a new cost-effective generic option, Cetrorelix Acetate for Injection, expanding its women’s health portfolio as a therapeutic equivalent to EMD Serono’s Cetrotide.
Cetrorelix Acetate for Injection is used in fertility treatments, specifically in assisted reproductive technologies like in vitro fertilization (IVF). It works by preventing premature ovulation during the treatment process
The company aims to offer comprehensive and affordable treatment choices for women’s health in the U.S. Visit Fresenius Kabi’s website for more details.
In simple terms, Cetrorelix helps ensure that the eggs are ready at the right time for fertilization, increasing the chances of a successful pregnancy.
Cetrorelix blocks the action of a natural hormone called gonadotropin-releasing hormone (GnRH). This hormone triggers the release of luteinizing hormone (LH), which leads to ovulation. Cetrorelix helps doctors control the timing of ovulation. This is crucial in fertility treatments, as it allows eggs to mature properly before they are collected for IVF.